Abdominal Stent Graft System Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Abdominal stent graft systems are tubular, fabric-covered metal mesh devices delivered via catheter to reinforce weakened sections of the abdominal aorta, preventing aneurysm rupture without the need for open surgical repair. This minimally invasive approach, known as endovascular aneurysm repair (EVAR), has become the standard of care for most AAA patients due to lower perioperative mortality, shorter hospital stays, and faster recovery times compared to traditional open repair.

The primary growth catalyst is the rising global prevalence of abdominal aortic aneurysms, particularly among aging male populations and smokers. Continued technological advancements in stent graft design, including branched and fenestrated grafts that expand treatment options for complex anatomies, further drive adoption. Expanding indications for EVAR in patients previously considered unsuitable for surgery, combined with growing healthcare expenditure in emerging economies, support sustained market expansion.

The market is segmented by product type, including bifurcated stent grafts, aorto-uni-iliac grafts, and modular devices, as well as by material composition and delivery system specifications. Geographically, North America commands the largest market share due to high procedure volumes, strong reimbursement coverage, and the presence of major device manufacturers. Europe represents the second-largest market, while the Asia-Pacific region is expected to exhibit the fastest growth, driven by improving healthcare infrastructure and rising disease awareness in countries such as China, India, and Japan.

What are the recent trends and outlook?

Emerging trends point toward continued expansion of minimally invasive treatment paradigms, with growing adoption of complex EVAR techniques using fenestrated and branched grafts that enable treatment of aneurysms involving critical aortic branches. Integration of advanced imaging guidance, robotic-assisted delivery systems, and bioresorbable stent technologies represent the next wave of innovation.